Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Position Cut by Moody Aldrich Partners LLC

Moody Aldrich Partners LLC trimmed its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 2.2% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 2,341 shares of the pharmaceutical company’s stock after selling 52 shares during the quarter. Moody Aldrich Partners LLC’s holdings in Vertex Pharmaceuticals […]

Related Keywords

Canada ,Virginia ,United States ,Amit Sachdev ,Sanfordc Bernstein ,Nasdaq ,Vertex Pharmaceuticals Incorporated ,Moody Aldrich Partners ,Macquarie Group Ltd ,Vertex Pharmaceuticals ,Cantor Fitzgerald ,Vertex Pharmaceuticals Trading ,Royal Bank ,Man Group ,Vertex Pharmaceuticals Company Profile ,Norges Bank ,Quarter For Vertex Pharmaceuticals ,Canaccord Genuity Group ,Morgan Stanley ,News Ratings For Vertex Pharmaceuticals Daily ,Free Report ,Aldrich Partners ,Virginia Retirement Systems ,Chairman Jeffrey ,Pharmaceuticals Incorporated ,Get Free Report ,Genuity Group ,Visit Holdingschannel ,Vertex Pharmaceuticals Daily ,Nasdaq Vrtx ,Vrtx ,Medical ,92532f10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,